Table 2.

Odds ratio and measures of validity for each group/subgroup at both Khorana score cutoff of ≥2 and ≥3.

Group/Subgroup	Khorana Cutoff	Odds Ratio	Confidence Interval	p Value	Sensitivity	Specificity	PPV	NPV	AUC	Likelihood Ratio (+)
All	K ≥ 2	1.17	0.40–3.39	0.77	0.72	0.31	0.068	0.94	0.51	1.05
All	K ≥ 3	1.69	0.61–4.69	0.35	0.33	0.77	0.092	0.94	0.55	1.46
ACT	K ≥ 2	1.05	0.31–3.53	0.94	0.69	0.32	0.056	0.95	0.51	1.02
ACT	K ≥ 3	2.69	0.84–8.65	0.09	0.38	0.81	0.11	0.96	0.60	2.04
NA/DCT	K ≥ 2	1.38	0.14–14.07	0.78	0.80	0.26	0.13	0.90	0.53	1.08
NA/DCT	K ≥ 3	0.27	0.027–2.61	0.25	0.20	0.51	0.056	0.82	0.64	0.41

ACT = adjuvant chemotherapy, K = Khorana score, NA/DCT = neoadjuvant/definitive chemotherapy, NPV = negative predictive value, PPV = positive predictive value,